DoD awards $32.8M contract for robotic pipette tip industrial base expansion to TECAN U.S., INC

Contract Overview

Contract Amount: $32,862,500 ($32.9M)

Contractor: Tecan U.S., Inc.

Awarding Agency: Department of Defense

Start Date: 2020-10-26

End Date: 2022-06-30

Contract Duration: 612 days

Daily Burn Rate: $53.7K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: Other

Official Description: COVID-19 TASK FORCE - ROBOTIC PIPETTE TIP INDUSTRIAL BASE EXPANSION - ACTION AWARDED UNDER CSO FA8730-20-S-0003.

Place of Performance

Location: MORRISVILLE, WAKE County, NORTH CAROLINA, 27560

State: North Carolina Government Spending

Plain-Language Summary

Department of Defense obligated $32.9 million to TECAN U.S., INC. for work described as: COVID-19 TASK FORCE - ROBOTIC PIPETTE TIP INDUSTRIAL BASE EXPANSION - ACTION AWARDED UNDER CSO FA8730-20-S-0003. Key points: 1. Contract aims to bolster domestic manufacturing capacity for critical medical supplies. 2. Awarded under a broad agency announcement, suggesting a focus on innovative solutions. 3. Fixed-price contract type helps control costs and provides budget certainty. 4. Performance period spans over 600 days, indicating a substantial project scope. 5. Geographic focus on North Carolina for industrial base expansion. 6. No small business set-aside, indicating a focus on large-scale industrial capacity.

Value Assessment

Rating: good

The contract value of $32.8 million for expanding the industrial base for robotic pipette tips appears reasonable given the strategic importance of such supplies, especially in the context of national health initiatives. Benchmarking against similar industrial base expansion contracts is challenging due to the specialized nature of the equipment and the specific geopolitical context. However, the firm fixed-price structure suggests an effort to manage costs effectively. The award to a single entity, TECAN U.S., INC., implies a belief in their capability to meet the outlined requirements.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. The specific mechanism used was a Broad Agency Announcement (BAA), which typically solicits proposals for basic and applied research and development. This suggests that the government was seeking innovative approaches to expanding the industrial base for robotic pipette tips. The number of bidders is not specified, but full and open competition generally leads to better price discovery and a wider range of potential solutions.

Taxpayer Impact: Full and open competition ensures that taxpayer dollars are used efficiently by fostering a competitive environment that drives down prices and encourages innovation. This approach maximizes the chances of securing the best value for the government and, by extension, the public.

Public Impact

Benefits the healthcare sector by ensuring a more robust supply chain for essential medical consumables. Supports the expansion of domestic manufacturing capabilities, reducing reliance on foreign sources. Potential for job creation in North Carolina's manufacturing and technology sectors. Enhances national preparedness for future public health emergencies. Provides critical components for diagnostic and research laboratories nationwide.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for supply chain disruptions if the sole awardee faces unforeseen production issues.
Dependence on a single contractor for a critical industrial base expansion could pose a risk.
The long-term sustainability of the expanded industrial base beyond the contract period needs consideration.

Positive Signals

Addresses a critical need for domestic production of essential medical supplies.
Utilizes a competitive process to ensure value for money.
Firm fixed-price contract provides cost certainty for the government.
Focus on industrial base expansion aligns with national security and public health objectives.

Sector Analysis

This contract falls within the broader industrial and manufacturing sector, specifically focusing on the expansion of the domestic supply chain for medical devices and consumables. The market for robotic pipette tips is driven by the increasing automation in laboratories for research, diagnostics, and drug discovery. The size of this specific niche market is difficult to quantify independently but is a critical component of the larger laboratory equipment and supplies industry, which is valued in the billions globally. This contract represents a strategic investment to ensure the resilience of this supply chain.

Small Business Impact

This contract was not set aside for small businesses, nor does it appear to have specific subcontracting requirements for small businesses mentioned in the provided data. The focus on expanding the industrial base for robotic pipette tips suggests a need for significant manufacturing capacity and technological expertise, which may favor larger, established firms. The absence of small business considerations could limit opportunities for smaller players in this specific initiative, though they may still participate in the broader supply chain.

Oversight & Accountability

The contract is managed by the Department of the Air Force, indicating established oversight mechanisms within the Department of Defense. As a definitive contract awarded under a Broad Agency Announcement, it likely involves programmatic oversight and milestone tracking. Transparency is generally maintained through federal contract databases. Inspector General jurisdiction would apply to ensure the proper use of funds and prevent fraud, waste, and abuse throughout the contract's lifecycle.

Related Government Programs

COVID-19 Response Contracts
Medical Supply Chain Resilience Initiatives
Domestic Manufacturing Expansion Programs
Robotic Automation in Healthcare

Risk Flags

Supply Chain Dependency
Industrial Base Scalability
Long-Term Demand Uncertainty

Frequently Asked Questions

What is this federal contract paying for?

Department of Defense awarded $32.9 million to TECAN U.S., INC.. COVID-19 TASK FORCE - ROBOTIC PIPETTE TIP INDUSTRIAL BASE EXPANSION - ACTION AWARDED UNDER CSO FA8730-20-S-0003.

Who is the contractor on this award?

The obligated recipient is TECAN U.S., INC..

Which agency awarded this contract?

Awarding agency: Department of Defense (Department of the Air Force).

What is the total obligated amount?

The obligated amount is $32.9 million.

What is the period of performance?

Start: 2020-10-26. End: 2022-06-30.

What is the track record of TECAN U.S., INC. in fulfilling large-scale industrial base expansion contracts, particularly for critical medical supplies?

TECAN U.S., INC. is a well-established company specializing in laboratory instruments, automation, and consumables, including liquid handling solutions like robotic pipette tips. While specific details on their track record with large-scale 'industrial base expansion' contracts are not publicly detailed in this award notice, their core business involves manufacturing and supplying these types of products. Their experience in producing and distributing laboratory automation and consumables suggests a foundational capability to scale production. However, the success of this specific contract will depend on their ability to rapidly expand capacity, manage supply chains for raw materials, and meet the stringent quality and delivery requirements set by the Department of Defense, especially under the pressures of a national health initiative.

How does the awarded amount of $32.8 million compare to typical investments in expanding manufacturing capacity for specialized medical supplies?

The $32.8 million award for expanding the industrial base for robotic pipette tips is a significant investment, reflecting the strategic importance of securing domestic production capabilities for critical medical supplies. Investments in manufacturing capacity can vary widely depending on the complexity of the product, the required scale of production, and the existing infrastructure. For specialized items like robotic pipette tips, which are essential for automated laboratory processes and diagnostics, this level of funding suggests a substantial expansion is planned, potentially involving new facilities, advanced automation, or significant upgrades to existing production lines. Benchmarking is difficult without more specific market data on the cost of establishing such capacity, but the amount indicates a serious commitment by the government to de-risk and bolster this segment of the supply chain.

What are the primary risks associated with this contract, and what mitigation strategies are likely in place?

Primary risks include potential supply chain disruptions for raw materials needed for pipette tip manufacturing, production delays due to unforeseen technical challenges or workforce issues, and the risk that the expanded capacity may not be fully utilized or sustainable after the contract period. Another risk is the dependence on a single contractor for a critical component. Mitigation strategies likely involve robust contract management by the Department of the Air Force, including regular progress reviews, performance monitoring, and potentially contingency planning for alternative suppliers or production methods. The firm fixed-price nature of the contract incentivizes the contractor to manage costs and timelines effectively. The government may also have clauses for addressing force majeure events and ensuring quality control throughout the production process.

What is the expected impact of this contract on the overall effectiveness and resilience of the U.S. healthcare supply chain?

This contract is expected to significantly enhance the effectiveness and resilience of the U.S. healthcare supply chain by increasing domestic production capacity for robotic pipette tips. These tips are crucial components in automated laboratory systems used for diagnostics, research, and drug development. By strengthening the U.S. industrial base for these items, the contract aims to reduce reliance on foreign sources, thereby mitigating risks associated with international supply chain disruptions, geopolitical tensions, or global health crises. A more robust domestic supply ensures that laboratories can maintain operations, accelerate research, and provide timely diagnostic testing, ultimately contributing to better public health outcomes and national preparedness.

How does this contract align with historical federal spending patterns related to industrial base expansion and critical supply chain security?

This contract aligns with a growing historical trend of federal spending focused on bolstering domestic industrial bases and securing critical supply chains, particularly in sectors deemed vital for national security and public health. Following lessons learned from previous supply chain vulnerabilities, including those highlighted during the COVID-19 pandemic, various government agencies have increased investments in domestic manufacturing capabilities. This includes initiatives aimed at reshoring production, diversifying supply sources, and investing in advanced manufacturing technologies. The Department of Defense, in particular, has a mandate to ensure the availability of critical components and systems, making this contract a logical extension of its role in safeguarding national interests through strategic industrial investments.

Industry Classification

NAICS: Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical Appliance and Supplies Manufacturing

Product/Service Code: INSTALLATION OF EQUIPMENT › INSTALLATION OF EQUIPMENT

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Tecan Group AG

Address: 9401 GLOBE CENTER DR STE 140, MORRISVILLE, NC, 27560

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign-Owned and U.S.-Incorporated Business, Not Designated a Small Business, Special Designations

Financial Breakdown

Contract Ceiling: $32,862,500

Exercised Options: $32,862,500

Current Obligation: $32,862,500

Contract Characteristics

Commercial Item: COMMERCIAL ITEM

Cost or Pricing Data: NO

Timeline